Consulting firm, on behalf of its client, a biopharmaceutical company.
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2021 | BRIDGEWAY ADVOCACY |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Termination (No Activity) |
— | |
| 2020 | BRIDGEWAY ADVOCACY |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report (No Activity) |
— | |
| 2020 | BRIDGEWAY ADVOCACY |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report (No Activity) |
— | |
| 2020 | BRIDGEWAY ADVOCACY |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | |
| 2020 | BRIDGEWAY ADVOCACY |
2nd Quarter (Apr 1 - June 30) Registration |
— |
| Firm | Filings | Expenses |
|---|---|---|
| BRIDGEWAY ADVOCACY | 5 | — |
| Issue | Activities |
|---|---|
| Pharmacy | 2 |